Migraine and Risk of Cardiovascular Disease in Women

作者: Tobias Kurth , J. Michael Gaziano , Nancy R. Cook , Giancarlo Logroscino , Hans-Christoph Diener

DOI: 10.1001/JAMA.296.3.283

关键词:

摘要: Background:The vascular component of the migrainespecificphysiologicprofileandtheobservedadversecardiovascular risk profile in migraineurs suggest an association between migraine and cardiovascular disease (CVD).Inwomen,migrainehasbeenassociatedwithincreased CVD, including coronary events. Compatible data men are lacking. Methods:Prospective cohort study 20084 aged 40to84yearsparticipatinginthePhysicians’HealthStudy. In yearly questionnaires, were asked for informationonmigraine,riskfactors,andtheoccurrenceofstudy end points. We classified as having if they indicated during first 5 years, after which timefollow-upbegan.Informationonaurawasnotavailable. All free CVD at start followup. During a mean 15.7 we followed up participants occurrence major event (nonfatal ischemic stroke, nonfatal myocardial infarction, or death from CVD). also evaluated individual points, revascularization, angina. Results: A total 1449 (7.2%) reported migraine, follow-up, 2236 events occurred. Compared with nonmigraineurs, who had multivariable-adjusted hazard ratios (95% confidence intervals) 1.24 (1.06-1.46; P=.008) 1.12 (0.84-1.50; P=.43) 1.42 (1.15-1.77;P.001) 1.05 (0.89-1.24; P=.54) revascularization,1.15(0.99-1.33;P=.068)forangina,and1.07 (0.80-1.43; P=.65) death. Conclusion: this large prospective apparently healthy men, was associated increased driven by infarction. Arch Intern Med. 2007;167:795-801

参考文章(49)
P. Mitchell, J. J. Wang, J. Currie, R. G. Cumming, W. Smith, Prevalence and vascular associations with migraine in older Australians. Australian and New Zealand Journal of Medicine. ,vol. 28, pp. 627- 632 ,(1998) , 10.1111/J.1445-5994.1998.TB00659.X
E. A. Wammes-van der Heijden, H. Rahimtoola, H.G.M. Leufkens, C. C. Tijssen, A. C.G. Egberts, Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. ,vol. 67, pp. 1128- 1134 ,(2006) , 10.1212/01.WNL.0000240128.76399.FA
Rod A Lea, Micky Ovcaric, James Sundholm, Leah Solyom, John MacMillan, Lyn R Griffiths, None, Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Molecular Brain Research. ,vol. 136, pp. 112- 117 ,(2005) , 10.1016/J.MOLBRAINRES.2005.01.006
W E Waters, M J Campbell, P C Elwood, Migraine, headache, and survival in women BMJ. ,vol. 287, pp. 1442- 1443 ,(1983) , 10.1136/BMJ.287.6403.1442
Amnon Mosek, Ronella Marom, Amos D. Korczyn, Natan Bornstein, A history of migraine is not a risk factor to develop an ischemic stroke in the elderly. Headache. ,vol. 41, pp. 399- 401 ,(2001) , 10.1046/J.1526-4610.2001.111006399.X
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, Julie E. Buring, Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer JAMA. ,vol. 294, pp. 56- 65 ,(2005) , 10.1001/JAMA.294.1.56
G. P. Anzola, M. Magoni, M. Guindani, L. Rozzini, G. D. Volta, Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study Neurology. ,vol. 52, pp. 1622- 1622 ,(1999) , 10.1212/WNL.52.8.1622
G. C. Hall, M. M. Brown, J. Mo, K. D. MacRae, Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice Neurology. ,vol. 62, pp. 563- 568 ,(2004) , 10.1212/01.WNL.0000110312.36809.7F
Monika Atiya, Tobias Kurth, Klaus Berger, Julie E. Buring, Carlos S. Kase, Interobserver Agreement in the Classification of Stroke in the Women's Health Study Stroke. ,vol. 34, pp. 565- 567 ,(2003) , 10.1161/01.STR.0000054159.21017.7C
R Hering-Hanit, Z Friedman, I Schlesinger, M Ellis, Evidence for activation of the coagulation system in migraine with aura Cephalalgia. ,vol. 21, pp. 137- 139 ,(2001) , 10.1046/J.1468-2982.2001.00181.X